What's Trending in Stocks Right Now
Discover which stock market news stories are capturing the most attention today. This page shows you the most-viewed articles on StockTitan, updated every minute based on real visitor traffic. See what tens of thousands of traders and investors are reading right now.
Why this matters: When a news story suddenly gets massive readership, it often indicates significant market interest in that stock or sector. By tracking the most popular articles, you can quickly identify which companies and events are drawing investor attention and potentially moving markets.
This isn't editorial content or sponsored placement—it's based purely on reader activity. Every story below earned its position through actual page views from real visitors, making this an authentic snapshot of what the trading community finds most interesting. Whether it's earnings reports, FDA decisions, merger news, or market analysis, the most-read stories rise to the top.
Updated Every Minute: Market sentiment shifts quickly. This ranking is recalculated every 60 seconds to reflect the latest reading trends. What's trending now could be completely different in an hour as new stories break and capture attention.
Nasdaq (NASDAQ:NDAQ) has proposed significant enhancements to its listing standards, introducing more stringent requirements for both initial and continued listings. Key changes include a $15 million minimum market value requirement for public float under the net income standard, an accelerated delisting process for companies with market value below $5 million, and a $25 million minimum public offering proceeds requirement for Chinese companies.
The proposal aims to strengthen investor protection and market integrity by addressing potential pump-and-dump schemes and evolving market dynamics. Implementation will occur promptly after SEC approval, with a 30-day grace period for companies in the initial listing process and 60 days for the new suspension and delisting requirements.
- Enhanced investor protection through stricter listing requirements
- Accelerated process for removing non-compliant companies
- Strengthened oversight of Chinese company listings
- Improved measures against potential market manipulation
- May reduce the number of eligible companies for listing
- Could potentially impact Nasdaq's listing revenue
- Stricter requirements might push some companies to alternative exchanges
Senseonics (NYSE American: SENS) announced a significant strategic shift in its Eversense 365 commercialization strategy. The company has signed a Memorandum of Understanding to take over all global commercialization and distribution from Ascensia Diabetes Care, effective January 1, 2026.
Key developments include the appointment of Brian Hansen as Chief Commercial Officer and an expanded debt facility up to $100 million with Hercules Capital to fund the commercial organization. The company expects 2025 global net revenue of $34-38 million and projects gross margin expansion to 50% in 2026, increasing to over 70% at scale.
For 2025, Senseonics anticipates doubling its global patient base, with gross margins between 32.5% and 37.5%. Cash used in operations is expected to be approximately $60 million.
- Gross margin expected to expand to 50% in 2026 and over 70% at scale
- Projected doubling of global patient base during 2025
- Secured up to $100 million non-dilutive debt facility with Hercules Capital
- Expected immediate revenue improvement through direct commercialization
- Appointment of experienced industry executive Brian Hansen as CCO
- Significant cash burn with $60 million expected to be used in operations for 2025
- Current gross margins remain relatively low at 32.5-37.5% for 2025
- Substantial investment required to build commercial infrastructure
- Operational risks associated with transitioning from partnership model to direct sales
Neonode (NASDAQ: NEON) announced anticipated proceeds from a patent lawsuit settlement between Samsung Electronics and Neonode Smartphone LLC (Aequitas Sub). While not directly involved in the lawsuit, Neonode expects to receive net proceeds of $15-20 million based on its 50% share agreement from a 2019 patent assignment to Aequitas Technologies LLC.
The settlement stems from a June 2020 lawsuit filed by Aequitas Sub against Samsung for patent infringement. The case was dismissed on September 2, 2025, following the settlement. A separate patent infringement case against Apple Inc. remains pending. The company's Board has not yet decided on the use of the settlement proceeds.
- Expected net proceeds of $15-20 million from the Samsung patent settlement
- Company maintains 50% share in potential future patent monetization proceeds
- Ongoing potential for additional revenue from pending Apple patent litigation
- Final proceeds subject to tax implications and other financial considerations
- No clear strategy announced for use of settlement proceeds
- Company not directly involved in litigation control or decisions
LifeVantage (Nasdaq:LFVN) has announced a strategic acquisition of LoveBiome, a direct sales company specializing in microbiome health solutions. The acquisition strengthens LifeVantage's position in the rapidly growing gut health market, which is projected to expand from $14.4 billion in 2025 to $32.4 billion by 2035.
The deal centers around LoveBiome's P84 product, which focuses on gut health regulation and restoration through Activation technology, complementing LifeVantage's existing portfolio including Protandim® and MindBody GLP-1 System™. The transaction is expected to close by mid-October 2025 and will be accretive to Adjusted EPS and EBITDA in the first year.
- Expected to be accretive to Adjusted EPS and Adjusted EBITDA in year one
- Expands market presence in US, Taiwan, and Europe through increased consultant network
- Enters growing gut health supplement market projected for 8.4% CAGR through 2035
- Acquisition includes retention of key LoveBiome personnel and leadership
- Integration and regulatory requirements pending completion
- Transaction value and financial terms not disclosed
AGNC Investment Corp. (Nasdaq: AGNC) has announced the pricing of a public offering of 12 million depositary shares at $25.00 per share, raising $300 million in gross proceeds. Each depositary share represents a 1/1,000th interest in the company's 8.75% Series H Fixed-Rate Cumulative Redeemable Preferred Stock.
The underwriters have a 30-day option to purchase up to 1.8 million additional shares for overallotments. The offering, expected to close around September 10, 2025, will be listed on Nasdaq under symbol "AGNCZ". AGNC plans to use the proceeds to acquire Agency and non-Agency securities, real estate-related assets, and for general corporate purposes.
- Raised $300 million in gross proceeds through preferred stock offering
- 8.75% fixed-rate dividend provides steady income stream for preferred shareholders
- Strong underwriting support from major financial institutions
- Potential dilution for existing shareholders
- Additional dividend payment obligations from new preferred stock
- Increased leverage through new preferred stock issuance
Concentrix (NASDAQ: CNXC), a global technology and services leader, has announced the acquisition of SAI Digital, an end-to-end digital commerce and customer experience technology solutions company. The strategic acquisition strengthens Concentrix's presence in Vietnam and enhances its digital capabilities across the Asia Pacific region.
SAI Digital brings expertise in e-commerce and technology solutions, featuring strategic partnerships with leading technology providers and a proprietary AI solution suite. The company's established delivery center in Vietnam supports clients across Japan, Korea, Singapore, and other APAC markets.
The integration aims to boost Concentrix's digital and AI capabilities, deepen regional expertise, and enhance offerings for clients seeking to optimize e-commerce performance and customer experiences. Financial terms of the transaction were not disclosed.
- Strategic expansion of digital commerce and CX technology capabilities in APAC region
- Access to SAI Digital's proprietary AI solution suite and technology partnerships
- Enhanced presence in Vietnam as a strategic delivery hub
- Strengthened capability to serve key APAC markets including Japan, Korea, and Singapore
- Financial terms and transaction value not disclosed, limiting assessment of deal impact
- Integration costs and potential challenges not addressed in the announcement
Figma (NYSE:FIG) reported strong Q2 2025 financial results with revenue reaching $249.6 million, up 41% year-over-year. The company achieved an operating margin of 1% with operating income of $2.1 million.
Key metrics include a 129% Net Dollar Retention Rate for customers with ARR over $10,000, and 11,906 paid customers contributing more than $10,000 in ARR. The company launched four new products: Figma Make, Draw, Sites, and Buzz, while completing acquisitions of Modyfi and Payload.
Looking ahead, Figma projects Q3 2025 revenue between $263.0-265.0 million (33% YoY growth) and full-year 2025 revenue of $1.021-1.025 billion (37% YoY growth). The company also announced early lock-up release terms and extended lock-up agreements affecting approximately 54.1% of outstanding Class A shares.
- Revenue grew 41% year-over-year to $249.6 million
- Strong Net Dollar Retention Rate of 129% for customers with ARR over $10,000
- Positive operating income of $2.1 million with 1% operating margin
- Robust cash position with $1.6 billion in cash and equivalents
- Strategic acquisitions of Modyfi and Payload strengthen product offerings
- 80% of customers use two or more products, showing strong platform adoption
- Healthy operating cash flow of $62.5 million with 25% margin
- Expected growth rate decline with Q3 guidance showing 33% YoY growth vs current 41%
- Elevated sales and marketing spend during Config conference impacting operating margins
- Early lock-up release may increase share supply and create selling pressure
- Operating margin remains relatively low at 1%
C3 AI (NYSE:AI) reported fiscal Q1 2026 results with total revenue of $70.3 million, including $60.3 million in subscription revenue. The company announced significant organizational changes, including the appointment of Stephen Ehikian as CEO effective September 1, 2025, with founder Thomas M. Siebel transitioning to Executive Chairman.
The quarter saw 46 closed agreements, including 28 initial production deployments. C3 AI launched its Strategic Integrator Program (SIP), an OEM initiative for partners to build Enterprise AI applications. The company's cash balance stands at $711.9 million. For Q2 FY2026, C3 AI projects revenue between $72.0-$80.0 million.
Financial performance included a GAAP net loss of $(0.86) per share and non-GAAP net loss of $(0.37) per share. The company withdrew its full-year fiscal 2026 guidance due to the leadership transition and sales reorganization.
- Launched Strategic Integrator Program (SIP) creating new OEM revenue opportunities
- Closed 46 agreements including 28 initial production deployments
- Strong cash position of $711.9 million
- Partner network pipeline increased 54% year-over-year
- Microsoft joint qualified pipeline grew 140% year-over-year
- Subscription revenue represents 86% of total revenue
- Q1 financial performance deemed 'completely unacceptable' by Chairman
- Withdrew full-year fiscal 2026 guidance
- GAAP net loss of $(0.86) per share
- Sales reorganization caused short-term disruption
- CEO's health issues impacted sales process participation
dLocal (NASDAQ:DLO), a technology-first payments platform, has announced a secondary offering of 15,000,000 Class A common shares by an entity affiliated with General Atlantic. The underwriters will have a 30-day option to purchase an additional 2,250,000 shares.
The offering is being led by J.P. Morgan, Goldman Sachs & Co. LLC, and Morgan Stanley as global coordinators and joint bookrunners, with BTG Pactual and Citigroup acting as joint bookrunners. dLocal will not receive any proceeds from this secondary offering as the company is not selling any shares.
- None.
- Significant shareholder General Atlantic reducing its stake through 15 million share sale
- Additional dilution possible through 2.25 million share overallotment option
- No proceeds will benefit the company as it's a secondary offering